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Background
Signalling by NO/cGMP is very important for regulation
of vascular tone and gastrointestinal motility. One impor-
tant signalling pathway of cGMP-dependent protein
kinase type I (cGKI) is mediated by IRAG (IP3 Receptor
Associated cGKI substrate) which is highly expressed in
smooth muscle of cardiovascular and gastrointestinal tis-
sue. In order to elucidate the physiological role of IRAG
we generated IRAG knockout mice by targeted deletion of
exon 3. These mice show an enlarged gastrointestinal tract
including pylorus stenosis.
Results
Exogenous and endogenous NO and cGMP stimulation
relaxes hormone induced contraction of wild type aortic
vessels as well as gastrointestinal tissues of colon and jeju-
num. This effect is significantly reduced in IRAG – defi-
cient animals. Furthermore, activation of particular
guanylyl cyclase by atrial natriuretic peptide (ANP) shows
a reduced relaxing effect in IRAG knockout tissue strips.
The expression levels of other cGKI substrates and the
NO-induced cGMP synthesis are not affected in these tis-
sues from IRAG KO mice.
Conclusion
These results indicate that IRAG signalling is essentiaI for
smooth muscle relaxation by NO/cGMP and ANP/cGMP.
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